CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY
Distal Left Main Coronary Disease Is a Major Predictor of Outcome in Patients Undergoing Percutaneous Intervention in the Drug-Eluting Stent Era
An Integrated Clinical and Angiographic Analysis Based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) Registries
Marco Valgimigli, MD,
Patrizia Malagutti, MD,
Gaston A. Rodriguez-Granillo, MD,
Héctor M. Garcia-Garcia, MD,
Jawed Polad, MBChB, MRCP,
Keiichi Tsuchida, MD, PhD,
Evelyn Regar, MD, PhD,
Willem J. Van der Giessen, MD, PhD,
Peter de Jaegere, MD, PhD,
Pim De Feyter, MD, PhD and
Patrick W. Serruys, MD, PhD*
Erasmus Medical Center, Thoraxcenter, Rotterdam, the Netherlands
Manuscript received October 2, 2005;
revised manuscript received October 28, 2005,
accepted November 8, 2005.
* Reprint requests and correspondence: Dr. Patrick W. Serruys, Thoraxcenter, Bd-406, Dr Molewaterplein 40, 3015-GD Rotterdam, the Netherlands (Email: p.w.j.c.serruys{at}erasmusmc.nl).
OBJECTIVES: This study sought to investigate whether the anatomical location of the disease carries prognostic implications in patients undergoing drug-eluting stent (DES) implantation for the left main coronary artery (LMCA) stenosis.
BACKGROUND: Liberal use of DES, compared with a bare metal stent (BMS), has resulted in an improved outcome in patients undergoing LMCA intervention. However, the overall event rate in this subset of patients remains high, and alternative tools to risk-stratify this population beyond conventional surgical risk status would be desirable.
METHODS: From April 2002 to June 2004, 130 patients received DES as part of the percutaneous intervention for LMCA stenoses in our institution. Distal LMCA disease (DLMD) was present in 94 patients. They were at higher surgical risk and presented with a greater coronary disease extent compared with patients without DLMD.
RESULTS: After a median of 587 days (range 368 to 1,179 days), the cumulative incidence of major adverse cardiac events (MACE) was significantly higher in patients with DLMD at 30% versus 11% in those without DLMD (hazard ratio [HR] 3.42, 95% confidence interval [CI] 1.34 to 9.7; p = 0.007), mainly driven by the different rate of target vessel revascularization (13% and 3%; HR 6, 95% CI 1.2 to 29; p = 0.02). After adjustment for confounders, DLMD (HR 2.79,95% CI 1.17 to 8.9; p = 0.032) and surgical risk status (HR 2.18,95% CI 1.06 to 4.5; p = 0.038) remained independent and complementary predictors of MACE.
CONCLUSIONS: Distal LMCA disease carries independent prognostic implications, and it may help in selecting the most appropriate patient subset for LMCA intervention beyond the conventional surgical risk status in the DES era.
|
Abbreviations and Acronyms
| | BMS = bare-metal stent | | DES = drug-eluting stent | | DLMD = distal left main disease | | LMCA = left main coronary artery | | MACE = major adverse cardiac events | | MI = myocardial infarction | | MLD = minimal luminal diameter | | SES = sirolimus-eluting stent | | TIMI = Thrombolysis In Myocardial Infarction | | TVR = target vessel revascularization |
|
This article has been cited by other articles:
|
|
|
|
 
R. J. Shemin
Coronary Artery Bypass Grafting Versus Stenting for Unprotected Left Main Coronary Artery Disease: Where Lies the Body of Proof?
Circulation,
December 2, 2008;
118(23):
2326 - 2329.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kaul, W. E. Boden, T. B. Ferguson Jr, R. A. Guyton, M. J. Mack, P. T. Sergeant, R. J. Shemin, P. K. Smith, S. Yusuf, and D. P. Taggart
Reply
J. Am. Coll. Cardiol.,
August 12, 2008;
52(7):
584 - 586.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Pocar, F. Donatelli, A. Moneta, H. Tomoda, J. A. Tayek, J. R. Arnold, A. P. Banning, S.-J. Park, D.-W. Park, and Y.-H. Kim
Stents versus bypass grafting for left main coronary artery disease.
N. Engl. J. Med.,
July 24, 2008;
359(4):
423 - 424.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. White, G. Kedia, J. M. Mirocha, M. S. Lee, J. S. Forrester, W. C. Morales, S. Dohad, S. Kar, L. S. Czer, G. P. Fontana, et al.
Comparison of Coronary Artery Bypass Surgery and Percutaneous Drug-Eluting Stent Implantation for Treatment of Left Main Coronary Artery Stenosis
J. Am. Coll. Cardiol. Intv.,
June 1, 2008;
1(3):
236 - 245.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. P. Taggart, S. Kaul, W. E. Boden, T. B. Ferguson Jr, R. A. Guyton, M. J. Mack, P. T. Sergeant, R. J. Shemin, P. K. Smith, and S. Yusuf
Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery.
J. Am. Coll. Cardiol.,
March 4, 2008;
51(9):
885 - 892.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Brinker
The left main facts: faced, spun, but alas too few.
J. Am. Coll. Cardiol.,
March 4, 2008;
51(9):
893 - 898.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. E. Kip, K. Hollabaugh, O. C. Marroquin, and D. O. Williams
The Problem With Composite End Points in Cardiovascular Studies The Story of Major Adverse Cardiac Events and Percutaneous Coronary Intervention.
J. Am. Coll. Cardiol.,
February 19, 2008;
51(7):
701 - 707.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Tsuchikane, T. Aizawa, H. Tamai, Y. Igarashi, K. Kawajiri, N. Ozawa, S. Nakamura, K. Oku, M. Kijima, T. Suzuki, et al.
Pre Drug-Eluting Stent Debulking of Bifurcated Coronary Lesions
J. Am. Coll. Cardiol.,
November 13, 2007;
50(20):
1941 - 1945.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Palmerini, F. Barlocco, A. Santarelli, L. Bacchi-Reggiani, C. Savini, E. Baldini, L. Alessi, M. Ruffini, G. Di Credico, G. Piovaccari, et al.
A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged >=75 years)
Eur. Heart J.,
November 2, 2007;
28(22):
2714 - 2719.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Colombo and A. Chieffo
Drug-Eluting Stent Update 2007: Part III: Technique and Unapproved/Unsettled Indications (Left Main, Bifurcations, Chronic Total Occlusions, Small Vessels and Long Lesions, Saphenous Vein Grafts, Acute Myocardial Infarctions, and Multivessel Disease)
Circulation,
September 18, 2007;
116(12):
1424 - 1432.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Chieffo, S. J. Park, M. Valgimigli, Y. H. Kim, J. Daemen, I. Sheiban, A. Truffa, M. Montorfano, F. Airoldi, G. Sangiorgi, et al.
Favorable Long-Term Outcome After Drug-Eluting Stent Implantation in Nonbifurcation Lesions That Involve Unprotected Left Main Coronary Artery: A Multicenter Registry
Circulation,
July 10, 2007;
116(2):
158 - 162.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, O. Ben-Yehuda, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, J. Narula, D. J. Sahn, et al.
Highlights of the Year in JACC 2006
J. Am. Coll. Cardiol.,
January 30, 2007;
49(4):
509 - 527.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Price and P. S. Teirstein
Reply
J. Am. Coll. Cardiol.,
October 17, 2006;
48(8):
1728 - 1729.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Kimmelstiel
Multislice Computed Tomography After Left Main Drug-Eluting Stenting: Are We Putting the CarT Before the Horse?
Circulation,
August 15, 2006;
114(7):
616 - 619.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Kereiakes and D. P. Faxon
Left Main Coronary Revascularization at the Crossroads
Circulation,
May 30, 2006;
113(21):
2480 - 2484.
[Full Text]
[PDF]
|
|
|
|
